Cargando…
Plasma osteopontin as a biomarker of Alzheimer’s disease and vascular cognitive impairment
Cerebrovascular disease (CeVD) and neurodegenerative dementia such as Alzheimer’s disease (AD) are frequently associated comorbidities in the elderly, sharing common risk factors and pathophysiological mechanisms including neuroinflammation. Osteopontin (OPN) is an inflammatory marker found upregula...
Autores principales: | Chai, Yuek Ling, Chong, Joyce R., Raquib, Ainiah R., Xu, Xin, Hilal, Saima, Venketasubramanian, Narayanaswamy, Tan, Boon Yeow, Kumar, Alan P., Sethi, Gautam, Chen, Christopher P., Lai, Mitchell K. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889621/ https://www.ncbi.nlm.nih.gov/pubmed/33597603 http://dx.doi.org/10.1038/s41598-021-83601-6 |
Ejemplares similares
-
Serum IL-8 is a marker of white-matter hyperintensities in patients with Alzheimer's disease
por: Zhu, Yanan, et al.
Publicado: (2017) -
Immunomodulatory sphingosine-1-phosphates as plasma biomarkers of Alzheimer’s disease and vascular cognitive impairment
por: Chua, Xin Ying, et al.
Publicado: (2020) -
Serum Hepatocyte Growth Factor Is Associated with Small Vessel Disease in Alzheimer’s Dementia
por: Zhu, Yanan, et al.
Publicado: (2018) -
Markers of Cardiac Dysfunction in Cognitive Impairment and Dementia
por: Hilal, Saima, et al.
Publicado: (2015) -
Elevated Soluble TNF-Receptor 1 in the Serum of Predementia Subjects with Cerebral Small Vessel Disease
por: Salai, Kaung H. T., et al.
Publicado: (2023)